Sanofi, Regeneron Shares Pop On Big News About COPD Treatment

Sanofi

Shares of Sanofi were up 10.20% the week ended March 24, while Regeneron finished with a gain of 9.68%, following promising news about the company’s jointly developed medication Dupixent. Clinical trial results showed the drug reduced severe flare-ups of COPD at a far better rate than a placebo. There are currently no equivalent treatments for […]